Matters relating to logistics, transport, and cold chain in respect to delivering the vaccines were also discussed during PM Modi's interaction with representatives of pharma companies

Prime Minister Narendra Modi on Monday held a virtual meeting with three teams working on developing and manufacturing vaccines for COVID-19. These teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad, and Dr. Reddy's Laboratories Ltd Hyderabad.

During the meeting, PM Modi appreciated the efforts being made by the scientists in these companies to come out with a vaccine solution to tackle COVID-19. The potential of various platforms for vaccine development was also discussed.

The Prime Minister also asked the companies to come out with their suggestions and ideas regarding the regulatory processes and related matters. He also suggested that they should take extra efforts to inform the general public in simple language about the vaccine and related matters such as its efficacy. Matters relating to logistics, transport, and cold chain in respect to delivering the vaccines were also discussed.

All the vaccine candidates discussed are at different stages of trials and detailed data and results are expected early next year onwards.

PM Modi advised all the departments concerned to engage with the manufacturers and seek to resolve matters so that the efforts of these companies bear fruit to serve the needs of the country and the entire world.

The Prime Minister has been reviewing the Covid-19 situation closely since India faced the second wave of the pandemic.

On Friday, the Prime Minister went on a three-city tour to personally review the development of the coronavirus vaccine and the manufacturing process.

He began the tour with a visit to pharma major Zydus Cadila's plant in Gujarat. From Ahmedabad, PM Modi flew to Hyderabad where he visited Bharat BioTech, which is working on Covaxin, pitched as India's first indigenous vaccine candidate.

After his hour-long visit to the facility, the PM proceeded to Pune where Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and Oxford University for a COVID-19 vaccine, is based.